FTV - Fortive Corp Stock Analysis
Fortive Corp (FTV) is a publicly traded company listed on the NYSE. It operates in the Scientific & Technical Instruments industry, part of the broader Technology sector. The company has a market capitalization of 17.46B, generates annual revenue of 5.64B, and reports net income of 602.30M. As of the latest data, the stock is trading at 54.96 USD.
From a valuation and risk perspective, the stock presents the following profile: The stock is moderately valued and aligns with market expectations for established companies. The PEG ratio is above 2, which could imply the stock is overvalued based on its growth outlook. The company maintains a healthy balance between debt and equity, which is typical for stable businesses. The dividend yield (0.54%) is modest, often associated with growth-oriented companies. The stock has average market volatility, aligning with general market movement.
Analyst recommendation stands at Hold (3.38), indicating current market sentiment. Institutional ownership is reported at 102.49%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of -6.33%, trading within a 52-week range of 45.49 - 62.77.
FTV - Fortive Corp
54.96
Analyst Consensus
Hold 3.38
FTV – Analyst Rating Summary
- Strong Buy: 2
- Buy: 5
- Hold: 17
- Sell: 0
- Strong Sell: 0
- Total Analysts: 24
| Index: | S&P 500 | P/E: | 31.38 | EPS (ttm): | 1.75 | Insider Own: | 0.47% | Shs Outstand: | 317.60M | Perf Week: | -0.07% |
| Market Cap: | 17.46B | Forward P/E: | 19.31 | EPS next Y: | 2.85 | Insider Trans: | -2.55% | Shs Float: | 316.13M | Perf Month: | 0.55% |
| Income(ttm): | 602.30M | PEG: | 13.79 | EPS next Q: | 0.84 | Inst Own: | 102.49% | Short Float: | 3.31% | Perf Quarter: | 12.88% |
| Revenue(ttm): | 5.64B | P/S: | 3.09 | EPS this Y: | -9.74% | Inst Trans: | -2.32% | Short Ratio: | 3.38 | Perf Half Y: | 8.77% |
| Book/sh: | 20.48 | P/B: | 2.68 | EPS next Y: | 7.59% | ROA: | 4.53% | Short Interest: | 10.45M | Perf Year: | -6.33% |
| Cash/sh: | 1.36 | P/C: | 40.52 | EPS next 5Y: | 1.40% | ROE: | 7.79% | 52W Range: | 45.49 - 62.77 | Perf YTD: | -0.45% |
| Dividend Est.: | 0.30 (0.54%) | P/FCF: | 15.76 | EPS past 3/5Y: | 13.17% 3.68% | ROIC: | 6.99% | 52W High: | 62.77 -12.44% | Beta: | 1.12 |
| Dividend TTM: | 0.24 (0.44%) | Quick Ratio: | 0.55 | Sales past 3/5Y: | 5.85% 6.43% | Gross Margin: | 60.33% | 52W Low: | 45.49 20.81% | Perf 5Y: | 2.62% |
| Dividend Ex-Date: | Nov 28, 2025 | Current Ratio: | 0.67 | EPS Y/Y TTM: | -30.29% | Oper. Margin: | 17.63% | RSI (14): | 51.23 | Volatility: | 1.98% 2.00% |
| Employees: | 18000 | Debt/Eq: | 0.51 | Sales Y/Y TTM: | -8.96% | Profit Margin: | 10.68% | Recom: | 3.00 | Target Price: | 57.75 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.33 | EPS Q/Q: | -73.77% | Payout: | 13.55% | Rel Volume: | 1.03 | Prev Close: | 55.51 |
| Sales Surprise: | 1.93% | EPS Surprise: | 19.42% | Sales Q/Q: | -33.07% | Earnings: | Feb 04 BMO | Avg Volume: | 3.09M | Price: | 54.96 |
| SMA20: | -0.50% | SMA50: | 2.22% | SMA200: | 7.02% | Undervalued: 5.08% | Volume: | 3,180,164 | Change: | -0.99% | |
Graham Classic formula value: 17.76
(P/E=8 * 1g) Min value: 14.77
(current P/E * 2g) Max value: 53.71
Average value: 28.75
About Fortive Corp
Fortive Corp. engages in the design, development, manufacturing, and marketing of professional and engineered products, software, and services for a variety of end markets. It operates through the following segments: Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. The Intelligent Operating Solutions segment provides solutions to accelerate industrial and facility reliability and performance, as well as compliance and safety across a range of vertical end markets, including manufacturing, process industries, healthcare, utilities and power, communications, and electronics. The Precision Technologies segment supplies technologies such as electrical test and measurement instruments and services, energetic material devices, and a broad portfolio of sensor and control system solutions. The Advanced Healthcare Solutions segment serves healthcare customers with products and services for critical activities, including instrument and device reprocessing, instrument tracking, cell therapy equipment design and manufacturing, biomedical test tools, radiation safety monitoring, and asset management. The company was founded by James A. Lico and Stacey A. Walker on November 10, 2015 and is headquartered in Everett, WA.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.